Akebia Therapeutics names Dave Spellman as Senior Vice President, Chief Financial Officer and Treasurer

Chartwell Partners is pleased to announce the recruitment of Dave Spellman as Senior Vice President, Chief Financial Officer and Treasurer for Akebia Therapeutics, (NASDAQ: AKBA), a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease.